AstraZeneca: Kidney Diseases trials

The registry lists 11 Kidney Diseases studies with AstraZeneca as lead sponsor. 0 are open to participants now and 4 have results posted.

Phase 1 2Phase 2 2Phase 3 4No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)CompletedNCT04724837Phase 2Results posted
• Savolitinib vs. Sunitinib in MET-driven PRCC.Active, not recruitingNCT03091192Phase 3Results posted
• Study to Characterize the Long-term Clinical Experience of Atacand in Hypertensive Children Ages 1 to<11 Years (Hypertension in Pediatrics)CompletedNCT00690612Phase 3Results posted
• 30 Week Study of the Combination of ABT-335 and Rosuvastatin Compared to Rosuvastatin Monotherapy for Subjects With Dyslipidemia and Stage 3 Chronic Kidney DiseaseCompletedNCT00680017Phase 3Results posted
• A Study to Investigate the Effects of Zibotentan/Dapagliflozin Combination Compared to Dapagliflozin Alone in Adult Participants With Chronic Kidney Disease and High ProteinuriaActive, not recruitingNCT06942910Phase 2
• OPTIMISE-CKD Study_current Clinical Landscape in SpainCompletedNCT06614712
• Study to Investigate Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin in Participants With Chronic Kidney Disease and High Proteinuria (ZENITH High Proteinuria)Active, not recruitingNCT06087835Phase 3
• A Study to Identify and Characterise Patients With Chronic Kidney Disease and ProteinuriaCompletedNCT05967806
• A Randomised, Open-Label Study to Evaluate the Relative and Absolute Bioavailability of Cotadutide in Healthy SubjectsCompletedNCT05294458Phase 1
• Evaluation of Target Organs Impairment on Patients Suffering From High Blood PressureCompletedNCT00925470
• A Safety Clinical Trial of Different Doses of MEDI-507 in the Prevention of Acute Renal Allograft RejectionCompletedNCT00807794Phase 1